1st Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for KYVERNA THERAPEUTICS, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to appropriations report language for Fiscal Year 2027.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA ABRAM | — |
| KANDIS MCCLURE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.